logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Manufacturers
    3. Bayshore Pharmaceuticals LLC

    Bayshore Pharmaceuticals LLC drugs

    FiltersReset Filters
    11 results
    • carvedilol

      (Carvedilol)
      Bayshore Pharmaceuticals LLC
      Usage: Carvedilol Tablets are indicated for the treatment of chronic heart failure, left ventricular dysfunction following myocardial infarction, and management of essential hypertension. It is used to improve survival, reduce hospitalization risk, and can be combined with other antihypertensive agents.
    • cyproheptadine hydrochloride

      (Cyproheptadine Hydrochloride)
      Bayshore Pharmaceuticals LLC
      Usage: This drug is indicated for perennial and seasonal allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild allergic skin conditions, cold urticaria, dermatographism, and as adjunctive therapy for anaphylactic reactions after initial control with epinephrine.
    • flecainide acetate

      (flecainide acetate)
      Bayshore Pharmaceuticals LLC
      Usage: Flecainide acetate tablets are indicated for preventing paroxysmal supraventricular tachycardias and paroxysmal atrial fibrillation/flutter in patients without structural heart disease. They are also used for life-threatening documented ventricular arrhythmias, but should not be used post-myocardial infarction or for less severe arrhythmias. Consideration of risks is essential.
    • metformin hydrochloride

      (Metformin hydrochloride)
      Bayshore Pharmaceuticals LLC
      Usage: Metformin hydrochloride extended-release tablets are indicated as an adjunct to diet and exercise for improving glycemic control in patients with type 2 diabetes mellitus.
    • methocarbamol

      (Methocarbamol)
      Bayshore Pharmaceuticals LLC
      Usage: Methocarbamol Tablets (500 mg and 750 mg) are indicated to relieve discomfort associated with acute, painful musculoskeletal conditions, as an adjunct to rest and physical therapy. Its exact mode of action is unclear, but it may involve sedative properties rather than direct muscle relaxation.
    • methscopolamine bromide

      (methscopolamine bromide)
      BAYSHORE PHARMACEUTICALS LLC
      Usage: Methscopolamine bromide is indicated as adjunctive therapy for the treatment of peptic ulcer. It is not effective in healing peptic ulcers, reducing recurrence rates, or preventing complications.
    • metolazone

      (Metolazone)
      Bayshore Pharmaceuticals LLC
      Usage: Metolazone tablets are indicated for treating salt and water retention related to edema from congestive heart failure and renal diseases. They are also used for hypertension, either alone or with other antihypertensives. In pregnancy, they are indicated for pathologic edema but not for physiological edema.
    • nadolol

      (Nadolol)
      Bayshore Pharmaceuticals LLC
      Usage: Nadolol tablets are indicated for long-term management of angina pectoris and for treating hypertension. The drug helps lower blood pressure, reducing the risk of cardiovascular events such as strokes and myocardial infarctions, and may be used alone or with other antihypertensive medications.
    • pindolol

      (pindolol)
      Bayshore Pharmaceuticals LLC
      Usage: Pindolol tablets are indicated for managing hypertension, either as a standalone treatment or in combination with other antihypertensive medications, especially thiazide-type diuretics.
    • sotalol

      (Sotalol Hydrochloride)
      Bayshore Pharmaceuticals LLC
      Usage: Sotalol Hydrochloride Tablets are indicated for treating life-threatening ventricular arrhythmias, such as sustained ventricular tachycardia. The drug may not improve survival rates and is generally not recommended for less severe arrhythmias due to the risk of proarrhythmic effects, including Torsade de Pointes.